Cargando…

Successful extended use of Impella 5.5 as a bridge to heart transplantation

We present the case of a 60-year-old gentleman who was admitted with acute-on-chronic cardiogenic shock and was supported with axillary Impella 5.5® for 123 days prior to heart transplantation. Total length of temporary mechanical circulatory support (MCS) was 132 days, which included 9 days with an...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharaf, Omar M, Diaz-Ayllon, Hannia P, Myers, Elisha M, Ahmed, Mustafa M, Bleiweis, Mark S, Jeng, Eric I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244061/
https://www.ncbi.nlm.nih.gov/pubmed/37293331
http://dx.doi.org/10.1093/jscr/rjad262
_version_ 1785054559461179392
author Sharaf, Omar M
Diaz-Ayllon, Hannia P
Myers, Elisha M
Ahmed, Mustafa M
Bleiweis, Mark S
Jeng, Eric I
author_facet Sharaf, Omar M
Diaz-Ayllon, Hannia P
Myers, Elisha M
Ahmed, Mustafa M
Bleiweis, Mark S
Jeng, Eric I
author_sort Sharaf, Omar M
collection PubMed
description We present the case of a 60-year-old gentleman who was admitted with acute-on-chronic cardiogenic shock and was supported with axillary Impella 5.5® for 123 days prior to heart transplantation. Total length of temporary mechanical circulatory support (MCS) was 132 days, which included 9 days with an intra-aortic balloon pump prior to Impella. During support, the patient remained extubated, participated in regular ambulation and rehabilitation with physical therapy and had continuous monitoring of device positioning. He did not experience any vascular or septic events while on temporary MCS and had improved hemodynamics and renal function after Impella initiation. Post-transplantation course was uncomplicated, and he is doing well without evidence for allograft dysfunction over 581 days post-transplantation. To our knowledge, this is the longest Impella 5.5®-supported patient during the new United Network for Organ Sharing Heart Allocation era who was successfully bridged to heart transplantation with over 1-year follow-up.
format Online
Article
Text
id pubmed-10244061
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-102440612023-06-08 Successful extended use of Impella 5.5 as a bridge to heart transplantation Sharaf, Omar M Diaz-Ayllon, Hannia P Myers, Elisha M Ahmed, Mustafa M Bleiweis, Mark S Jeng, Eric I J Surg Case Rep Case Report We present the case of a 60-year-old gentleman who was admitted with acute-on-chronic cardiogenic shock and was supported with axillary Impella 5.5® for 123 days prior to heart transplantation. Total length of temporary mechanical circulatory support (MCS) was 132 days, which included 9 days with an intra-aortic balloon pump prior to Impella. During support, the patient remained extubated, participated in regular ambulation and rehabilitation with physical therapy and had continuous monitoring of device positioning. He did not experience any vascular or septic events while on temporary MCS and had improved hemodynamics and renal function after Impella initiation. Post-transplantation course was uncomplicated, and he is doing well without evidence for allograft dysfunction over 581 days post-transplantation. To our knowledge, this is the longest Impella 5.5®-supported patient during the new United Network for Organ Sharing Heart Allocation era who was successfully bridged to heart transplantation with over 1-year follow-up. Oxford University Press 2023-06-05 /pmc/articles/PMC10244061/ /pubmed/37293331 http://dx.doi.org/10.1093/jscr/rjad262 Text en Published by Oxford University Press and JSCR Publishing Ltd. © The Author(s) 2023. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Sharaf, Omar M
Diaz-Ayllon, Hannia P
Myers, Elisha M
Ahmed, Mustafa M
Bleiweis, Mark S
Jeng, Eric I
Successful extended use of Impella 5.5 as a bridge to heart transplantation
title Successful extended use of Impella 5.5 as a bridge to heart transplantation
title_full Successful extended use of Impella 5.5 as a bridge to heart transplantation
title_fullStr Successful extended use of Impella 5.5 as a bridge to heart transplantation
title_full_unstemmed Successful extended use of Impella 5.5 as a bridge to heart transplantation
title_short Successful extended use of Impella 5.5 as a bridge to heart transplantation
title_sort successful extended use of impella 5.5 as a bridge to heart transplantation
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244061/
https://www.ncbi.nlm.nih.gov/pubmed/37293331
http://dx.doi.org/10.1093/jscr/rjad262
work_keys_str_mv AT sharafomarm successfulextendeduseofimpella55asabridgetohearttransplantation
AT diazayllonhanniap successfulextendeduseofimpella55asabridgetohearttransplantation
AT myerselisham successfulextendeduseofimpella55asabridgetohearttransplantation
AT ahmedmustafam successfulextendeduseofimpella55asabridgetohearttransplantation
AT bleiweismarks successfulextendeduseofimpella55asabridgetohearttransplantation
AT jengerici successfulextendeduseofimpella55asabridgetohearttransplantation